Integrated Diagnostics Holdings Plc

Integrated Diagnostics (IDHC)

Buy
Sell
Company name:Integrated Diagnostics Holdings Plc
EPIC:IDHCTrading Currency:USD
Market Sector:SMEVISIN:JE00BV9H9G76
Market Segment:SSMUShare Type:DE
WWW Address:http://www.idhcorp.com/Description:ORD USD1.00
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 3.70 images.advfn.com/imagesnew/2/gb/down -0.03 [-0.80] 3.70 3.74 3.65 3.70 3.65 4,771
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 555.42 150.11 0.00 16.29 - 22.72 - 4.75 - 2.80

Integrated Diagnostics Key Figures

(at previous day's close)
Market Cap.555.42m
Shares In Issue150.11m
Prev. Close3.73
PE Ratio22.72 
Dividend Yield-%
EPS - basic16.29¢($)
Dividend PS-¢($)
Dividend Cover- 
Cash Flow PS21.80¢($)
Return On Equity (ROE)23.06%
Operating Margin34.05%
PEG Factor12.68 
EPS Growth Rate1.79%
Dividends PS Growth Rate-%
Net Debt46.27m
Gross Gearing37.15%
Quick Assets34.34m
Net Working Capital-0.56m
Intangibles / Fixed Assets65.52%
Turnover PS69.59¢($)
Pre-Tax Profit PS23.70¢($)
Retained Profit PS1.89¢($)
Cash PS12.79¢($)
Net Cash PS-13.10¢($)
Net Tangible Asset Value PS *9.06¢($)
Net Asset Value PS73.77¢($)
Spread0.04 (1.07%) 

Integrated Diagnostics Balance Sheet

LSE:IDHC:Liabilities+EQLSE:IDHC:Assets

Share Price Performance

Sample Period HighLow
1 week3.913.55
4 weeks4.203.55
12 weeks4.203.39
1 year4.752.80

Share Price Chart (5 years)

Integrated Diagnostics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3.83-0.13-3.393.550.123.74
4 weeks3.70--3.550.113.84
12 weeks3.80-0.10-2.633.390.113.74
26 weeks3.650.051.372.990.083.65
1 year4.51-0.81-17.962.800.063.72
3 years4.90-1.20-24.492.800.074.24
5 years5.05-1.35-26.732.200.074.05

Integrated Diagnostics Key Management Ratios

Integrated Diagnostics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio24.92 
PE Ratio22.72 
Tobin's Q Ratio 0.15 
Tobin's Q Ratio (excl. intangibles)0.31 
Dividend Yield-%
Market-to-Book Ratio5.34 
Price-to-Pre-Tax Profit PS15.61 
Price-to-Retained Profit PS195.89 
Price-to-Cash Flow PS16.97 
Price-to-Sales PS5.32 
Price-to-Net Tangible Asset Value PS27.23 
Price-to-Cash PS28.93 
Net Working Capital PS-0.37 
Price Pct to Working Capital PS-991.82%
Earnings Yield4.40%
Average PE0.02 
Years in average5 
PE to PE average100,506.55%

Integrated Diagnostics Financial Ratios

(Leverage Ratios)
Debt Ratio19.37%
Debt-to-Equity Ratio0.24 
Debt-to-Equity Ratio (excl. Intgbl)1.30 
Debt-to-Equity Market Value0.05 
Net Gearing26.26%
Net Gearing (excl. Intangibles)53.89%
Gross Gearing37.15%
Gross Gearing (excl. Intangibles)76.25%
Gearing Under 1 Year22.05%
Gearing Under 1 Year (excl. Intgbl)45.26%
Assets/Equity1.59 
Cash/Equity17.33 
(Liquidity Ratios)
Net Working Capital to Total Assets-0.32%
Current Ratio0.99 
Quick Ratio (Acid Test)0.88 
Liquidity Ratio0.49 
Cash & Equiv/Current Assets50.12%
(Solvency Ratios)
Enterprise Value569.61m
CFO/Sales0.31 
CFO/Attributable Profit1.36 
CFO/Assets0.19 
CFO/Debt0.50 
Total Debt/Equity Market Value0.12 
Total Debt/Sales0.63 
Total Debt/Pre-Tax Profit1.84 
Total Debt65.46m
Total Debt/Net Current Assets-116.90%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth11.05%
5 yr Compound Earnings Growth28.59%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
0.00030.0011

Integrated Diagnostics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)25.90%
Return On Assets (ROA)0.67%
Net Profit Margin22.95%
Assets Turnover0.03 
Return On Equity (ROE)23.06%
Return On Investment (ROI)0.84%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio1.07%
Net Income Of Revenues2.71%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.05 
Fixed Assets Turnover0.04 
Current Assets Turnover0.13 
Net Working Capital Turnover 
Inventory Turnover1.19 
(Other Operating Ratios)
Total Assets-to-Sales34.41 
Debtors-to-Sales298.08%
Debt Collection Period1,087.98Days

Integrated Diagnostics Dividends

Sorry No Data Available

Integrated Diagnostics Fundamentals

 31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)
turnover1,170.62100.00%1,514.26100.00%1,921.45100.00%2,226.49100.00%m
pre tax profit388.5433.19%558.4336.88%717.3637.33%758.1434.05%m
attributable profit260.4022.24%374.0224.70%502.0926.13%510.9322.95%m
retained profit260.4022.24%-2.72-0.18%67.143.49%60.432.71%m
eps - basic174.00 249.00 335.00 341.00 
eps - diluted174.00 249.00 335.00 341.00 
dividends per share- - - - 

Integrated Diagnostics Balance Sheet

 31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)
LSE:IDHC:Liabilities+EQLSE:IDHC:AssetsLSE:IDHC:Liabilities+EQLSE:IDHC:AssetsLSE:IDHC:Liabilities+EQLSE:IDHC:AssetsLSE:IDHC:Liabilities+EQLSE:IDHC:Assets
 31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)
ASSETS
fixed assets fixed assets391.1412.84%473.7915.23%705.7820.55%785.5520.92%m
intangibles intangibles1,643.6053.96%1,658.2553.29%1,672.4648.71%1,925.6051.27%m
fixed investments fixed investments95.583.14%9.150.29%239.906.99%228.016.07%m
current assets - other current assets - other--%--%--%--%m
stocks stocks51.721.70%69.942.25%91.082.65%84.342.25%m
debtors debtors166.685.47%202.266.50%299.998.74%322.808.60%m
cash & securities cash & securities696.9722.88%698.4422.44%424.5712.36%409.1410.89%m
TOTAL3,045.68100%3,111.81100%3,433.79100%3,755.44100%m
LIABILITIES
creditors - short creditors - short481.7515.82%485.4115.60%669.3219.49%828.2222.05%m
creditors - long creditors - long264.478.68%312.3110.04%363.8310.60%566.9615.10%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL746.2224.50%797.7225.64%1,033.1530.09%1,395.1837.15%m
EQUITY
ord cap, reserves ord cap, reserves2,237.3073.46%2,245.5972.16%2,270.0566.11%2,215.5559.00%m
prefs, minorities prefs, minorities62.162.04%68.502.20%130.593.80%144.713.85%m
TOTAL2,299.4675.50%2,314.0974.36%2,400.6469.91%2,360.2662.85%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Integrated Diagnostics Cash Flow Statement

31 Dec 2016 (EGP)31 Dec 2017 (EGP)31 Dec 2018 (EGP)31 Dec 2019 (EGP)
Operating CF398.66403.08556.31697.41m
Pre-Financing CF261.13369.1890.69561.06m
Retained CF142.93-1.64-268.0412.33m

Integrated Diagnostics Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
IDHC
Integrated..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201203 12:39:30